At Baylor College of Medicine, Hecker and colleagues demonstrate that psilocybin’s active metabolite, psilocin, extends human lung and skin cell lifespans by up to 57%, preserves telomere length, and reduces oxidative stress. In parallel, monthly psilocybin dosing in older mice improves survival rates to 80%, reverses hair loss, and restores hair color, highlighting its potential to modulate key aging hallmarks through telomere maintenance and stress resilience mechanisms.
Key points
Psilocin extends human lung and skin cell lifespan by up to 57%, maintaining telomere length and reducing oxidative stress.
Monthly psilocybin administration in aged mice increases survival from 50% to 80%, promotes fur regrowth, and reverses hair graying.
Study highlights the role of telomere stabilization and Sirt1-mediated stress resilience as mechanisms underpinning psilocybin’s anti-aging effects.
Why it matters:
This study reveals that a psychedelic compound can directly target aging biomarkers, potentially opening novel therapeutic strategies for age-related diseases.
Q&A
What are telomeres?
How does psilocybin influence cellular aging pathways?
Why use mice models for aging research?
Are there safety or dosage concerns with using psilocybin for anti-aging?
Read full article
Academy
Telomeres and Their Role in Aging
Telomeres are protective DNA–protein complexes capping the ends of chromosomes, composed of repetitive nucleotide sequences (TTAGGG in humans) bound by a specialized shelterin protein complex. They prevent chromosomal ends from being recognized as DNA damage and ensure complete replication of genetic material during cell division. Each mitotic cycle results in incremental telomere shortening due to the end-replication problem, eventually triggering cellular senescence or apoptosis when critically short.
Structure and Function:
- Telomeric DNA: Tandem repeats of 5–10 kilobases in somatic cells.
- Shelterin Complex: Six proteins (TRF1, TRF2, TIN2, RAP1, TPP1, POT1) that protect telomeres and regulate access of telomerase.
- Telomerase Enzyme: A ribonucleoprotein reverse transcriptase that adds telomeric repeats to counteract shortening, active in stem cells and some immune cells but repressed in most somatic tissues.
Telomere Shortening and Senescence: Progressive shortening limits cellular proliferation (the Hayflick limit) and promotes a senescence-associated secretory phenotype (SASP), characterized by inflammatory cytokine release. Accumulation of senescent cells contributes to tissue dysfunction and chronic age-related pathologies, making telomere preservation a central goal in longevity science.
Measurement and Intervention: Telomere length can be assayed by quantitative PCR, Southern blotting of terminal restriction fragments, or single telomere length analysis (STELA). Experimental strategies to maintain telomere length include telomerase activation, shelterin stabilization, and reducing oxidative stress to slow telomere attrition.
Psilocybin and Longevity Research
Psilocybin is a naturally occurring psychedelic alkaloid found in certain mushroom species. In vivo, psilocybin rapidly dephosphorylates to produce the active metabolite psilocin, which primarily targets serotonin (5-HT) receptors in the central nervous system. Recent research extends its application beyond neuropsychiatric therapy into aging biology.
Mechanisms of Anti-Aging Action:
- Telomere Preservation: Psilocin treatment in human lung and skin cells maintains telomere length by modulating telomerase activity and reducing replicative loss.
- Oxidative Stress Reduction: Treated cells exhibit lower levels of reactive oxygen species (ROS) and improved antioxidant defenses, limiting damage to DNA and proteins.
- Sirt1 Upregulation: Psilocin increases expression of Sirt1, a NAD+-dependent deacetylase linked to metabolic regulation, DNA repair, and stress resistance—key features of longevity pathways.
Preclinical Evidence: In aged mouse models (19-month-old females), monthly psilocybin dosing boosts survival rates from 50% to 80%, reverses age-related fur loss, and restores hair pigmentation. These outcomes correlate with preserved telomeres, enhanced tissue regeneration, and improved systemic resilience.
Implications for Longevity Science: The convergence of psychedelic pharmacology with anti-aging mechanisms opens new research avenues. Future studies must optimize dosing regimens, assess long-term safety, and evaluate translatability to human aging and age-related disorders, potentially transforming therapeutic approaches to extend healthy lifespan.
